Impact of counterfeits on the pharmaceutical industry: Counterfeiting poses threats to patient safety and revenues of pharmaceutical companies

Publication date: June 2011
Report format: electronic (.PDF) file
Pricing:

- Single user license: $3,500
- Site license: $7,000
- Global site license: $10,500

A 10% discount is available on all orders placed before 31st December 2011. Please contact us for further information.

---

Report Description

Impact of counterfeits on pharmaceutical industry: Counterfeiting poses threats to patient safety and revenues of pharmaceutical companies provides in-depth analysis of trends, issues and challenges in this industry. The report analyzes the effects of counterfeits on the pharmaceutical industry in the US, Europe and the Rest of the World. Further, the report provides an analysis on the technologies and solutions that are used to eliminate or prevent counterfeiting of drugs. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts.

Scope

The scope of this report includes:

• Challenges facing the pharmaceutical industry.
• Sources of counterfeiting in the pharmaceutical industry.
• Analysis of the impact of counterfeiting in the pharmaceutical industry.
• Key technologies and solutions that are developed to reduce counterfeiting.
• Competitive benchmarking of leading technology solutions companies in the market.

Reasons to Buy

The report will enhance your decision making capability. It will allow you to:

• Assess impact of counterfeiting on pharmaceutical sales, distribution and other functions.
• Identify solutions and technologies that are useful against counterfeiting of drugs.
• Identify best practices in the industry through analyses of solutions developed by industry leaders.
• Strengthen security of supply chain through case studies of implementation of technologies.

---